Medrx News

Medrx: Notice regarding the recording of non-operating expenses

Nov 8 14:30

Medrx: Summary of Financial Results for the 3rd Quarter Ending 2024/12 [Japanese GAAP] (Consolidated)

Nov 8 14:30

Medrx: Notice regarding the monthly exercise status of the 29th Stock Acquisition Rights (with exercise price amendment clause) issued by third party allotment

Nov 1 07:50

Medrx: Notice of commencement of MRX-7MLL clinical trials

Oct 28 14:00

Medrx: Notice regarding the monthly exercise status of the 29th Stock Acquisition Rights (with exercise price amendment clause) issued by third party allotment

Oct 1 07:50

Medrx: Notice Concerning Mass Exercise of the 29th Stock Acquisition Rights (with Exercise Price Amendment Clauses) Issued by Third Party Allotment

Sep 24 15:00

Medrx: Notice regarding the Reiwa 6th SME Overseas Expansion Support Project Cost Subsidy (Overseas Application Support Project) Indirect Subsidy Grant Decision

Sep 24 14:00

Medrx: Notice of Patent Assessment (Japan) relating to MRX-4TZT

Sep 5 16:00

Medrx: Change Report (short-term mass transfer)

Sep 4 11:09

Medrx: Notice regarding the monthly exercise status of the 29th Stock Acquisition Rights (with exercise price amendment clause) issued by third party allotment

Sep 2 07:50

Medrx: Change Report

Aug 26 12:57

Medrx: Financial results presentation for the second quarter of the fiscal year ending December 2024.

Aug 22 07:50

Medrx: Change Report

Aug 21 12:04

Medrx: Announcement of the massive exercise of the 29th subscription rights (with an exercise price adjustment clause) issued by third-party allotment.

Aug 19 15:00

Medrx: Change Report

Aug 15 11:36

Medrx: Announcement of the massive exercise of the 29th subscription rights (with an exercise price adjustment clause) issued by third-party allotment.

Aug 14 15:00

Medrx: Confirmatory letter.

Aug 9 14:01

Medrx: Announcements of individual stocks regarding the modification clause of the exercise price by third-party allocation and the 25th, 28th, and 29th subscription rights, and the change in the expected timing of expenditure of procurement funds.

Aug 9 14:00

Medrx: Announcement of differences between financial estimates and actual results for the second quarter (interim period) of the fiscal year ending December 2024.

Aug 9 14:00

Medrx: Announcements of individual stocks regarding the recognition of non-operating income, non-operating expenses and special profits

Aug 9 14:00